ReportsnReports

US Chronic Pain Therapy Market - Focus on Opioids: Market Size, Share, Growth Drivers, Trends and Forecasts to 2019

MarketReportsOnline.com adds "The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019)" report to its research store.

 

Dallas, TX -- (SBWIRE) -- 06/30/2015 -- Chronic pain, defined as pain that lasts longer than six months and about 100 million Americans suffer from chronic pain that could be mild or agonizing, episodic or continuous, merely inconvenient or totally incapacitating.

The US chronic pain therapy market is expected to experience slow pace of growth in the near future. The major opioids used for medication in chronic pain are Oxycodone, Hydrocodone, Fentanyl, Methadone, Morphine, Hydromorphone and Dihydrocodeine. Compared to other opioids, hydrocodone products, the most commonly prescribed opioid and the most commonly prescribed pharmaceutical products in the United States, are growing at a substantial pace in the overall chronic pain therapy market. In the oxycodone business domain, the expected launch of Egalet 002 in the second quarter of 2015 by the leading player Egalet will change the dynamics of this domain as currently Oxycotin dominates the oxycodone market.

Complete report available at http://www.marketreportsonline.com/376611.html.

Segment Coverage of Chronic Pain Market: Oxycodone, Hydrocodone, Morphine, Hydromorphone, Fentanyl, Dihydrocodeine & Methadone

The report titled "The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)" provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs involved in the treatment of chronic pain. The chronic pain market report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall chronic pain therapy market has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Further, key players of the industry like Zogenix Inc., Egalet Corporation and NektarTheropeutics are profiled.

Purchase a copy of "Chronic Pain" research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=376611.

Major points from Table of Contents are listed below:

1.Executive summary
2.Introduction: Chronic Pain
3.The US Chronic Pain Therapy Market
4. The US Chronic Pain Therapy Market: Segment Analysis
5. The US Chronic Pain Therapy: Market Share Analysis
6. Growth Drivers and Challenges:The US Chronic Pain Therapy Market
7. The US Chronic Pain Therapy Market Trends
8. Competitive Landscape:The US Chronic Pain Therapy Market
9. Company Profiles:The US Chronic Pain Therapy Market
List of Tables and Figures

Other Related Reports on Pharmaceuticals Market Research Report:

Research on China Anesthetic Industry , 2015 (http://www.marketreportsonline.com/413614.html) With the increasing numbers of domestic surgeries, the market size of Chinese anesthetic also increased a lot. The market size of Chinese anesthetic industry reached nearly RMB 6400 million in 2014, increased by 18.8% from a YoY base. Among which, General anesthesia accounts for around 69% of the total market size.

Global Hemophilia Market Report: 2015 Edition (http://www.marketreportsonline.com/409838.html) Hemophilia is an inherited or acquired bleeding disorder that prevents blood from clotting. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. People with hemophilia do not bleed any faster than normal, but they can bleed for a longer time. Hemophilia is quite rare and about 1 in 10,000 people are born with it, around 0.42 million people live with hemophilia. Hemophilia patients need to replace the missing factor through infusions.

Ebola Partnering 2010-2015 (http://www.marketreportsonline.com/408385.html) The report provides an analysis of ebola partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ebola technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com